REPL
Replimune Group, Inc. · Healthcare
Chief Commercial Officer Christopher Sarchi sold $52K of Replimune Group, Inc.
Sold$52,065
$8.01Price
6,500Shares
−4%Stake
What REPL did after the filing
- The stock from Tue, Apr 7 open, $8.62
- −45.5%
- S&P 500, same days
- +11.7%
Measured over 30 trading days, to the May 19 close.
Traded Thu, Apr 2. Filed Mon, Apr 6, 4:30 PM ET, after the close. Returns use the Apr 7 open and the May 19 close. Not investment advice.